Global Health Data Exchange - Discover the World's Health Data

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Nav

General Info
Geography 
Argentina (ARG)
Australia (AUS)
Austria (AUT)
Belgium (BEL)
Brazil (BRA)
Canada (CAN)
China (CHN)
Hong Kong
Denmark (DNK)
Finland (FIN)
France (FRA)
Germany (DEU)
Hungary (HUN)
Israel (ISR)
Italy (ITA)
Malaysia (MYS)
Mexico (MEX)
Poland (POL)
Portugal (PRT)
Singapore (SGP)
Sweden (SWE)
Port of Spain
Puerto Rico
Time period covered 
01/1996 - 12/2000
Citation
Authors 
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, Collaborative Study Group
Journal 
N Engl J Med
Volume 
345
Issue 
12
Pages 
851-60
Publication year 
2001
Suggested citation 
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I, Collaborative Study Group. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001; 345(12): 851-60.